Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-30

Clinical Trial Update: Preoperative Melatonin to Decrease Analgesia Usage After Third Molar Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial completed evaluating whether preoperative melatonin reduces analgesic (narcotic) use after third molar extraction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Pain, Postoperative, Narcotic Use | Phase 2 | Status: COMPLETED